LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

Market Cap	4.35B -10.9%
Revenue (ttm)	926.49M +1.7%
Net Income	58.84M +8.8%
EPS	0.12 +8.8%
Shares Out	510.66M
PE Ratio	73.95
Forward PE	n/a
Dividend	0.02 (0.24%)
Ex-Dividend Date	Jun 26, 2026

Volume	18,623,400
Open	8.85
Previous Close	8.18
Day's Range	8.34 - 8.85
52-Week Range	6.63 - 11.02
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHE:002644

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional Chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; pre-packaged food; processing and selling of Chinese herbal medicine pieces; technology development, and professional and technical services; inspection and testi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,332
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002644

Financial Performance

In 2025, SHE:002644's revenue was 915.53 million, a decrease of -6.60% compared to the previous year's 980.23 million. Earnings were 49.21 million, a decrease of -18.08%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error